Clin2
NCT07184814Possibly a fitRecruiting

Takayasu's arteritis with lung artery involvement study

Takayasu Arteritis With Pulmonary Artery InvolvementPulmonary Arterial Hypertension Associated With Connective Tissue Disease

Part of Heart & circulation, Immune system & allergy, Lungs & breathing clinical trials.

This study looks at people with Takayasu's arteritis that also affects the lungs' blood vessels. Researchers want to understand the disease's behavior and outcomes over time.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
150 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have been diagnosed with Takayasu's arteritis (a rare disease that causes inflammation of the large blood vessels).
  • You have lung artery involvement from this condition, confirmed by a special CT scan or angiogram.
  • Your hospitalization for this study must have occurred between January 2016 and December 2026.
  • If you have lung artery narrowing from other causes (like other types of blood vessel disease, blood clots, or tumors), you cannot join.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05388682Recruiting
Treating Takayasu disease with lung artery involvement

This trial studies treatment for people with Takayasu arteritis when it affects the lung arteries. It may help reduce problems caused by narrowed or involved lung arteries.

Beijing
NCT03372980Recruiting
Study registry of blood tests for Takayasu arteritis

This study collects information and blood samples (biomarkers) to better understand Takayasu arteritis and how active it is. It may help researchers find tests that support diagnosis and track disease activity.

Beijing, Beijing Municipality
NCT02964364Recruiting
Registry for people with Takayasu arteritis

This is a patient registry that collects information about people with Takayasu arteritis. It helps researchers better understand the condition and how it affects blood flow in the arms and other major vessels.

Beijing, Beijing Municipality
NCT07451665Not yet recruiting· Phase 4
Testing two drugs for active Takayasu's arteritis

This study tests two new medications, vunakizumab and ivarmacitinib, for people with active Takayasu's arteritis (TAK) that is not fully controlled by standard treatments. The goal is to see if these drugs are safe and effective for reducing disease activity.

Beijing, Beijing Municipality
NCT03169010Recruiting
Study registry for rare lung artery blood pressure problems

This study collects information from people with rare types of pulmonary hypertension (high blood pressure in the lungs) and from healthy volunteers. It helps researchers better understand these conditions, especially using a special lung-heart test to confirm the diagnosis.

Beijing, Beijing Municipality
NCT06178419Recruiting
Remote Conditioning for Brain Ischemia in Takayasu Arteritis

This trial tests whether gentle, repeated blood pressure cuff inflations on the arm can improve blood flow to the brain in people with Takayasu arteritis. It's for those with inactive disease and narrowed brain arteries but who still have low brain blood flow.

Beijing, Beijing Municipality

Hear when a new Takayasu Arteritis With Pulmonary Artery Involvement trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.